|
9271 |
Zoledronsäure: Ist q12w so wirksam wie q4w?
Enthalten in InFo Onkologie Bd. 20, 2.11.2017, Nr. 7, date:11.2017: 24-26
|
|
|
|
9272 |
Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer—a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
Enthalten in Supportive care in cancer Bd. 31, 19.12.2022, Nr. 1, date:1.2023: 1-9
|
|
|
|
9273 |
Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial
Enthalten in Trials Bd. 19, 27.12.2018, Nr. 1, date:12.2018: 1-9
|
|
|
|
9274 |
Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia
Enthalten in Psychopharmacology Bd. 150, 1.6.2000, Nr. 3, date:6.2000: 237-243
|
|
|
|
9275 |
ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial
Enthalten in Nature Communications Bd. 14, 12.10.2023, Nr. 1, date:12.2023: 1-11
|
|
|
|
9276 |
Zu Joggern 10 Meter Abstand einhalten!
Enthalten in MMW - Fortschritte der Medizin Bd. 162, 30.4.2020, Nr. 8, date:4.2020: 10
|
|
|
|
9277 |
Zu Unrecht nicht empfohlen?
Enthalten in Info Neurologie & Psychiatrie Bd. 20, 20.8.2018, Nr. 7-8, date:8.2018: 25
|
|
|
|
9278 |
Zugelassen: Glatirameracetat dreimal wöchentlich
Enthalten in Info Neurologie & Psychiatrie Bd. 17, 25.3.2015, Nr. 3, date:3.2015: 58
|
|
|
|
9279 |
Zukunftsboard Digitalisierung will Debatte anstoßen
Enthalten in Info Diabetologie Bd. 13, 1.6.2019, Nr. 3, date:6.2019: 51
|
|
|
|
9280 |
Zulassung eines antiviralen Medikaments zur CMV-Infektionsprophylaxe in der EU empfohlen
Enthalten in Im Focus Onkologie Bd. 20, 16.12.2017, Nr. 12, date:12.2017: 77
|
|
Administration
